91ÊÓƵ

91ÊÓƵ Pharmaceuticals Inc. U.S. was formed for commercialization activities in the U.S. 

Commences U.S. Branded Business with the launch of Suprax®

Receives US FDA approval for New Lovastatin Plant at Tarapur

Acquires the U.S. Rights for Antara®

Becomes the 5th largest generic player in the U.S.

Inaugurates new Center of Excellence for Inhalation Research in Coral Springs, Florida

By acquiring Novel Laboratories, Inc., 91ÊÓƵ created 91ÊÓƵ Somerset, 91ÊÓƵ’s first U.S. based commercial manufacturing facility

Acquires Symbiomix Therapeutics, LLC in New Jersey for the launch of Solosec®

Solosec® (secnidazole) launched in the U.S.

91ÊÓƵ launches Tiotropium Dry Powder Inhaler for the treatment of COPD in the United States

91ÊÓƵ Enters the S&P Global Sustainability Yearbook 2024